LGCmain
Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 417
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

ORIGINAL ARTICLE

HER 2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization

Shirsat Hemlata S, Epari Sridhar, Shet Tanuja, Bagal Rajani, Hawaldar Rohini, Desai Sangeeta B

Year : 2012| Volume: 55| Issue : 2 | Page no: 175-179

   This article has been cited by
 
1 Assessment of the methods used to detect HER2-positive advanced extramammary Pagetís disease
Ikuko Hirai,Keiji Tanese,Yoshio Nakamura,Atsushi Otsuka,Yasuhiro Fujisawa,Yuki Yamamoto,Hiroo Hata,Taku Fujimura,Shigeto Matsushita,Koji Yoshino,Kaori Kameyama,Masayuki Amagai,Takeru Funakoshi
Medical Oncology. 2018; 35(6)
[Pubmed]  [Google Scholar] [DOI]
2 Fluorescence in-situ hybridization versus chromogenic in-situ hybridization in evaluating HER2 status in breast cancer by adopting tissue microarray technique
Samir Amer,Rasha Khairy,Omnia M. Badawy,Riham Farouk,Amira Raafat
Egyptian Journal of Pathology. 2017; 37(1): 182
[Pubmed]  [Google Scholar] [DOI]

 

Read this article